Basic Genomics AB focuses on advanced RNA sequencing technologies that facilitate the precise detection and quantification of RNA molecules. Their flagship BaseCode platform is designed to empower researchers and clinicians by providing critical insights into gene regulation, disease mechanisms, and potential therapeutic targets. This technology aims to unlock the full potential of RNA research, contributing to a deeper understanding of biological processes and the development of innovative health solutions.

The company emphasizes the importance of RNA research in addressing significant questions in biology and medicine. By leveraging their advanced sequencing capabilities, Basic Genomics AB seeks to enhance the ability of scientists to explore complex biological systems, ultimately leading to improved health outcomes. Their commitment to advancing RNA research positions them as a key player in the field, with the potential to drive significant advancements in understanding and treating various diseases.

Sweden

Basic Genomics AB is a technology-driven life science company that pioneers the characterization of nucleic acid molecules in single cells. We provide the missing layer in single-cell sequencing by enabling cost-efficient analysis of RNA isoforms in health and disease.

Basic Genomics AB

Company Details